The global Small Molecule Targeted Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Small Molecule Targeted Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Small Molecule Targeted Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Molecule Targeted Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Small Molecule Targeted Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Molecule Targeted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Molecule Targeted Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Small Molecule Targeted Therapy Market Report

Report Metric	Details
Report Name	Small Molecule Targeted Therapy Market
CAGR	5%
Segment by Type	TKI Multitarget Inhibitor Others
Segment by Application	Liver Cancer Colorectal Cancer Lung Cancer Gastric Cancer Breast Cancer Esophageal Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Small Molecule Targeted Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Molecule Targeted Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Small Molecule Targeted Therapy Market report?

Ans: The main players in the Small Molecule Targeted Therapy Market are Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai, Pfizer, Bristol-Myers Squibb, Roche, Bettapharma

What are the Application segmentation covered in the Small Molecule Targeted Therapy Market report?

Ans: The Applications covered in the Small Molecule Targeted Therapy Market report are Liver Cancer, Colorectal Cancer, Lung Cancer, Gastric Cancer, Breast Cancer, Esophageal Cancer, Others

What are the Type segmentation covered in the Small Molecule Targeted Therapy Market report?

Ans: The Types covered in the Small Molecule Targeted Therapy Market report are TKI, Multitarget Inhibitor, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 TKI

1.2.3 Multitarget Inhibitor

1.2.4 Others

1.3 Market by Application

1.3.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Liver Cancer

1.3.3 Colorectal Cancer

1.3.4 Lung Cancer

1.3.5 Gastric Cancer

1.3.6 Breast Cancer

1.3.7 Esophageal Cancer

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule Targeted Therapy Market Perspective (2019-2030)

2.2 Global Small Molecule Targeted Therapy Growth Trends by Region

2.2.1 Small Molecule Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Small Molecule Targeted Therapy Historic Market Size by Region (2019-2024)

2.2.3 Small Molecule Targeted Therapy Forecasted Market Size by Region (2025-2030)

2.3 Small Molecule Targeted Therapy Market Dynamics

2.3.1 Small Molecule Targeted Therapy Industry Trends

2.3.2 Small Molecule Targeted Therapy Market Drivers

2.3.3 Small Molecule Targeted Therapy Market Challenges

2.3.4 Small Molecule Targeted Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Small Molecule Targeted Therapy by Players

3.1.1 Global Small Molecule Targeted Therapy Revenue by Players (2019-2024)

3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Small Molecule Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Small Molecule Targeted Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Small Molecule Targeted Therapy Market Concentration Ratio

3.4.1 Global Small Molecule Targeted Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Therapy Revenue in 2023

3.5 Global Key Players of Small Molecule Targeted Therapy Head office and Area Served

3.6 Global Key Players of Small Molecule Targeted Therapy, Product and Application

3.7 Global Key Players of Small Molecule Targeted Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targeted Therapy Breakdown Data by Type

4.1 Global Small Molecule Targeted Therapy Historic Market Size by Type (2019-2024)

4.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2025-2030)

5 Small Molecule Targeted Therapy Breakdown Data by Application

5.1 Global Small Molecule Targeted Therapy Historic Market Size by Application (2019-2024)

5.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Small Molecule Targeted Therapy Market Size (2019-2030)

6.2 North America Small Molecule Targeted Therapy Market Size by Type

6.2.1 North America Small Molecule Targeted Therapy Market Size by Type (2019-2024)

6.2.2 North America Small Molecule Targeted Therapy Market Size by Type (2025-2030)

6.2.3 North America Small Molecule Targeted Therapy Market Share by Type (2019-2030)

6.3 North America Small Molecule Targeted Therapy Market Size by Application

6.3.1 North America Small Molecule Targeted Therapy Market Size by Application (2019-2024)

6.3.2 North America Small Molecule Targeted Therapy Market Size by Application (2025-2030)

6.3.3 North America Small Molecule Targeted Therapy Market Share by Application (2019-2030)

6.4 North America Small Molecule Targeted Therapy Market Size by Country

6.4.1 North America Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Small Molecule Targeted Therapy Market Size by Country (2019-2024)

6.4.3 North America Small Molecule Targeted Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Small Molecule Targeted Therapy Market Size (2019-2030)

7.2 Europe Small Molecule Targeted Therapy Market Size by Type

7.2.1 Europe Small Molecule Targeted Therapy Market Size by Type (2019-2024)

7.2.2 Europe Small Molecule Targeted Therapy Market Size by Type (2025-2030)

7.2.3 Europe Small Molecule Targeted Therapy Market Share by Type (2019-2030)

7.3 Europe Small Molecule Targeted Therapy Market Size by Application

7.3.1 Europe Small Molecule Targeted Therapy Market Size by Application (2019-2024)

7.3.2 Europe Small Molecule Targeted Therapy Market Size by Application (2025-2030)

7.3.3 Europe Small Molecule Targeted Therapy Market Share by Application (2019-2030)

7.4 Europe Small Molecule Targeted Therapy Market Size by Country

7.4.1 Europe Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Small Molecule Targeted Therapy Market Size by Country (2019-2024)

7.4.3 Europe Small Molecule Targeted Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Small Molecule Targeted Therapy Market Size (2019-2030)

8.2 China Small Molecule Targeted Therapy Market Size by Type

8.2.1 China Small Molecule Targeted Therapy Market Size by Type (2019-2024)

8.2.2 China Small Molecule Targeted Therapy Market Size by Type (2025-2030)

8.2.3 China Small Molecule Targeted Therapy Market Share by Type (2019-2030)

8.3 China Small Molecule Targeted Therapy Market Size by Application

8.3.1 China Small Molecule Targeted Therapy Market Size by Application (2019-2024)

8.3.2 China Small Molecule Targeted Therapy Market Size by Application (2025-2030)

8.3.3 China Small Molecule Targeted Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Small Molecule Targeted Therapy Market Size (2019-2030)

9.2 Asia Small Molecule Targeted Therapy Market Size by Type

9.2.1 Asia Small Molecule Targeted Therapy Market Size by Type (2019-2024)

9.2.2 Asia Small Molecule Targeted Therapy Market Size by Type (2025-2030)

9.2.3 Asia Small Molecule Targeted Therapy Market Share by Type (2019-2030)

9.3 Asia Small Molecule Targeted Therapy Market Size by Application

9.3.1 Asia Small Molecule Targeted Therapy Market Size by Application (2019-2024)

9.3.2 Asia Small Molecule Targeted Therapy Market Size by Application (2025-2030)

9.3.3 Asia Small Molecule Targeted Therapy Market Share by Application (2019-2030)

9.4 Asia Small Molecule Targeted Therapy Market Size by Region

9.4.1 Asia Small Molecule Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Small Molecule Targeted Therapy Market Size by Region (2019-2024)

9.4.3 Asia Small Molecule Targeted Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Astrazeneca

11.1.1 Astrazeneca Company Details

11.1.2 Astrazeneca Business Overview

11.1.3 Astrazeneca Small Molecule Targeted Therapy Introduction

11.1.4 Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.1.5 Astrazeneca Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Small Molecule Targeted Therapy Introduction

11.2.4 Novartis Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Millennium Pharmaceuticals

11.3.1 Millennium Pharmaceuticals Company Details

11.3.2 Millennium Pharmaceuticals Business Overview

11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Introduction

11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.3.5 Millennium Pharmaceuticals Recent Developments

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Small Molecule Targeted Therapy Introduction

11.4.4 Bayer Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.4.5 Bayer Recent Developments

11.5 Exelixis

11.5.1 Exelixis Company Details

11.5.2 Exelixis Business Overview

11.5.3 Exelixis Small Molecule Targeted Therapy Introduction

11.5.4 Exelixis Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.5.5 Exelixis Recent Developments

11.6 Abbvie

11.6.1 Abbvie Company Details

11.6.2 Abbvie Business Overview

11.6.3 Abbvie Small Molecule Targeted Therapy Introduction

11.6.4 Abbvie Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.6.5 Abbvie Recent Developments

11.7 Boehringer-Ingelheim

11.7.1 Boehringer-Ingelheim Company Details

11.7.2 Boehringer-Ingelheim Business Overview

11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Introduction

11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.7.5 Boehringer-Ingelheim Recent Developments

11.8 Eisai

11.8.1 Eisai Company Details

11.8.2 Eisai Business Overview

11.8.3 Eisai Small Molecule Targeted Therapy Introduction

11.8.4 Eisai Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.8.5 Eisai Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Small Molecule Targeted Therapy Introduction

11.9.4 Pfizer Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.9.5 Pfizer Recent Developments

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Details

11.10.2 Bristol-Myers Squibb Business Overview

11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Introduction

11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.10.5 Bristol-Myers Squibb Recent Developments

11.11 Roche

11.11.1 Roche Company Details

11.11.2 Roche Business Overview

11.11.3 Roche Small Molecule Targeted Therapy Introduction

11.11.4 Roche Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.11.5 Roche Recent Developments

11.12 Bettapharma

11.12.1 Bettapharma Company Details

11.12.2 Bettapharma Business Overview

11.12.3 Bettapharma Small Molecule Targeted Therapy Introduction

11.12.4 Bettapharma Revenue in Small Molecule Targeted Therapy Business (2019-2024)

11.12.5 Bettapharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Novartis

Millennium Pharmaceuticals

List of Tables

Table 1. Global Small Molecule Targeted Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of TKI

Table 3. Key Players of Multitarget Inhibitor

Table 4. Key Players of Others

Table 5. Global Small Molecule Targeted Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Small Molecule Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Small Molecule Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Small Molecule Targeted Therapy Market Share by Region (2019-2024)

Table 9. Global Small Molecule Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Small Molecule Targeted Therapy Market Share by Region (2025-2030)

Table 11. Small Molecule Targeted Therapy Market Trends

Table 12. Small Molecule Targeted Therapy Market Drivers

Table 13. Small Molecule Targeted Therapy Market Challenges

Table 14. Small Molecule Targeted Therapy Market Restraints

Table 15. Global Small Molecule Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Small Molecule Targeted Therapy Revenue Share by Players (2019-2024)

Table 17. Global Top Small Molecule Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Therapy as of 2023)

Table 18. Global Small Molecule Targeted Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Small Molecule Targeted Therapy, Headquarters and Area Served

Table 21. Global Key Players of Small Molecule Targeted Therapy, Product and Application

Table 22. Global Key Players of Small Molecule Targeted Therapy, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Small Molecule Targeted Therapy Revenue Share by Application (2019-2024)

Table 30. Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Small Molecule Targeted Therapy Revenue Share by Application (2025-2030)

Table 32. North America Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Small Molecule Targeted Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Small Molecule Targeted Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Small Molecule Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Small Molecule Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Small Molecule Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Small Molecule Targeted Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Small Molecule Targeted Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Small Molecule Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Small Molecule Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Small Molecule Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Small Molecule Targeted Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Small Molecule Targeted Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Small Molecule Targeted Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Small Molecule Targeted Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Small Molecule Targeted Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Small Molecule Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Small Molecule Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 64. Astrazeneca Company Details

Table 65. Astrazeneca Business Overview

Table 66. Astrazeneca Small Molecule Targeted Therapy Product

Table 67. Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 68. Astrazeneca Recent Developments

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Small Molecule Targeted Therapy Product

Table 72. Novartis Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 73. Novartis Recent Developments

Table 74. Millennium Pharmaceuticals Company Details

Table 75. Millennium Pharmaceuticals Business Overview

Table 76. Millennium Pharmaceuticals Small Molecule Targeted Therapy Product

Table 77. Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 78. Millennium Pharmaceuticals Recent Developments

Table 79. Bayer Company Details

Table 80. Bayer Business Overview

Table 81. Bayer Small Molecule Targeted Therapy Product

Table 82. Bayer Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 83. Bayer Recent Developments

Table 84. Exelixis Company Details

Table 85. Exelixis Business Overview

Table 86. Exelixis Small Molecule Targeted Therapy Product

Table 87. Exelixis Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 88. Exelixis Recent Developments

Table 89. Abbvie Company Details

Table 90. Abbvie Business Overview

Table 91. Abbvie Small Molecule Targeted Therapy Product

Table 92. Abbvie Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 93. Abbvie Recent Developments

Table 94. Boehringer-Ingelheim Company Details

Table 95. Boehringer-Ingelheim Business Overview

Table 96. Boehringer-Ingelheim Small Molecule Targeted Therapy Product

Table 97. Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 98. Boehringer-Ingelheim Recent Developments

Table 99. Eisai Company Details

Table 100. Eisai Business Overview

Table 101. Eisai Small Molecule Targeted Therapy Product

Table 102. Eisai Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 103. Eisai Recent Developments

Table 104. Pfizer Company Details

Table 105. Pfizer Business Overview

Table 106. Pfizer Small Molecule Targeted Therapy Product

Table 107. Pfizer Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 108. Pfizer Recent Developments

Table 109. Bristol-Myers Squibb Company Details

Table 110. Bristol-Myers Squibb Business Overview

Table 111. Bristol-Myers Squibb Small Molecule Targeted Therapy Product

Table 112. Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 113. Bristol-Myers Squibb Recent Developments

Table 114. Roche Company Details

Table 115. Roche Business Overview

Table 116. Roche Small Molecule Targeted Therapy Product

Table 117. Roche Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 118. Roche Recent Developments

Table 119. Bettapharma Company Details

Table 120. Bettapharma Business Overview

Table 121. Bettapharma Small Molecule Targeted Therapy Product

Table 122. Bettapharma Revenue in Small Molecule Targeted Therapy Business (2019-2024) & (US$ Million)

Table 123. Bettapharma Recent Developments

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Small Molecule Targeted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Small Molecule Targeted Therapy Market Share by Type: 2023 VS 2030

Figure 3. TKI Features

Figure 4. Multitarget Inhibitor Features

Figure 5. Others Features

Figure 6. Global Small Molecule Targeted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Small Molecule Targeted Therapy Market Share by Application: 2023 VS 2030

Figure 8. Liver Cancer Case Studies

Figure 9. Colorectal Cancer Case Studies

Figure 10. Lung Cancer Case Studies

Figure 11. Gastric Cancer Case Studies

Figure 12. Breast Cancer Case Studies

Figure 13. Esophageal Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. Small Molecule Targeted Therapy Report Years Considered

Figure 16. Global Small Molecule Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Small Molecule Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Small Molecule Targeted Therapy Market Share by Region: 2023 VS 2030

Figure 19. Global Small Molecule Targeted Therapy Market Share by Players in 2023

Figure 20. Global Top Small Molecule Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Therapy as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Small Molecule Targeted Therapy Revenue in 2023

Figure 22. North America Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Small Molecule Targeted Therapy Market Share by Type (2019-2030)

Figure 24. North America Small Molecule Targeted Therapy Market Share by Application (2019-2030)

Figure 25. North America Small Molecule Targeted Therapy Market Share by Country (2019-2030)

Figure 26. United States Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Small Molecule Targeted Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Small Molecule Targeted Therapy Market Share by Type (2019-2030)

Figure 30. Europe Small Molecule Targeted Therapy Market Share by Application (2019-2030)

Figure 31. Europe Small Molecule Targeted Therapy Market Share by Country (2019-2030)

Figure 32. Germany Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Small Molecule Targeted Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Small Molecule Targeted Therapy Market Share by Type (2019-2030)

Figure 40. China Small Molecule Targeted Therapy Market Share by Application (2019-2030)

Figure 41. Asia Small Molecule Targeted Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Small Molecule Targeted Therapy Market Share by Type (2019-2030)

Figure 43. Asia Small Molecule Targeted Therapy Market Share by Application (2019-2030)

Figure 44. Asia Small Molecule Targeted Therapy Market Share by Region (2019-2030)

Figure 45. Japan Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Country (2019-2030)

Figure 55. Brazil Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Small Molecule Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Astrazeneca Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 62. Novartis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 63. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 64. Bayer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 65. Exelixis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 66. Abbvie Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 67. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 68. Eisai Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 69. Pfizer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 71. Roche Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 72. Bettapharma Revenue Growth Rate in Small Molecule Targeted Therapy Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-17Q10023

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-8U10163

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11I9951

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34H832

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Small Molecule Targeted Therapy Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-25J13464

Global Small Molecule Targeted Therapy Market Insights, Forecast to 2030

FEATURED COMPANIES

Small Molecule Targeted Therapy Market Size

Small Molecule Targeted Therapy Market

Scope of Small Molecule Targeted Therapy Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Small Molecule Targeted Therapy Market report?

What are the Application segmentation covered in the Small Molecule Targeted Therapy Market report?

What are the Type segmentation covered in the Small Molecule Targeted Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS